Compare $BCDA vs $INTI | Chartloom

Compare

$BCDA vs $INTI

BioCardia Inc · Inhibitor Therapeutics Inc

BCDA

BioCardia Inc

INTI

Inhibitor Therapeutics Inc

Compare $BCDA vs $INTI

Comparing BioCardia Inc and Inhibitor Therapeutics Inc

BCDABioCardia Inc

INTIInhibitor Therapeutics Inc

BCDABioCardia Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.1%

52W performance

-26.8%

FCF yield

-48.9%

INTIInhibitor Therapeutics Inc

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

108.5%

52W performance

127.9%

FCF yield

-19.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCDA

INTI

Detailed metrics comparison

BCDA

BioCardia Inc

INTI

Inhibitor Therapeutics Inc

Market Cap

BCDA$15M

INTI$17M

Enterprise Value

BCDA$11M

INTI$16M

Price

BCDA$1.04

INTI$0.10

P/E Ratio

BCDAN/A

INTIN/A

P/S Ratio

BCDA36.53x

INTI4.25x

EV/Sales

BCDA26.98x

INTI4.12x

EV/EBITDA

BCDA4.97x

INTI1.61x

P/B Ratio

BCDA5.83x

INTI4,922.43x

P/FCF Ratio

BCDAN/A

INTIN/A

EV/FCF

BCDA-1.50x

INTI-5.09x

PEG Ratio

BCDAN/A

INTIN/A

Forward P/E (NTM)

BCDAN/A

INTIN/A

Forward P/S (NTM)

BCDAN/A

INTIN/A

Revenue (TTM)

BCDA$0

INTI$0

Revenue Growth (YoY)

BCDAN/A

INTIN/A

Forward Rev Growth

BCDA0.0%

INTI0.0%

Gross Margin (TTM)

BCDA100.0%

INTI20.9%

Operating Margin (TTM)

BCDA0.0%

INTI0.0%

EBITDA Margin (TTM)

BCDA0.0%

INTI0.0%

Net Margin (TTM)

BCDA0.0%

INTI0.0%

FCF Margin (TTM)

BCDAN/A

INTIN/A

Net Income (TTM)

BCDA$-6M

INTI$-3M

FCF (TTM)

BCDA$-8M

INTI$-3M

EPS (TTM)

BCDA$0.00

INTI$0.00

ROE (TTM)

BCDA-22168.0%

INTI-33792.0%

ROA (TTM)

BCDA-26166.0%

INTI-12210.0%

ROIC (TTM)

BCDA-22168.0%

INTI-33792.0%

Cash

BCDA$4M

INTI$516K

Debt

BCDA$0

INTI$0

Net Cash/Debt

BCDA$4M

INTI$516K

Current Ratio (TTM)

BCDA2.09x

INTI3.36x

Quick Ratio (TTM)

BCDA2.02x

INTI2.95x

Debt/Equity (TTM)

BCDA0.00x

INTI0.00x

Debt/Assets (TTM)

BCDA0.0%

INTI0.0%

Interest Coverage (TTM)

BCDAN/A

INTIN/A

Net Debt/EBITDA (TTM)

BCDA0.00x

INTI0.00x

Beta

BCDA0.63

INTI-0.79

52W Performance

BCDA-26.8%

INTI127.9%

YTD Performance

BCDA-18.1%

INTI108.5%

% from 52W High

BCDA-42.2%

INTI-21.0%

% from 52W Low

BCDA38.7%

INTI180.0%

Asset Turnover (TTM)

BCDA0.14x

INTI0.50x

FCF Yield (TTM)

BCDA-48.9%

INTI-19.1%

Earnings Yield (TTM)

BCDA-37.8%

INTI-15.9%

Dividend Yield (TTM)

BCDAN/A

INTIN/A

Rule of 40

BCDA0.0

INTI0.0

EV/GP/RG

BCDAN/A

INTIN/A

Ticker research

View BCDA research View INTI research

Metric	BCDA BioCardia Inc	INTI Inhibitor Therapeutics Inc
Market & Valuation
Market Cap	$15M	$17M
Enterprise Value	$11M	$16M
Price	$1.04	$0.10
P/E Ratio	N/A	N/A
P/S Ratio	36.53x	4.25x
EV/Sales	26.98x	4.12x
EV/EBITDA	4.97x	1.61x
P/B Ratio	5.83x	4,922.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.50x	-5.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	20.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-3M
FCF (TTM)	$-8M	$-3M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-22168.0%	-33792.0%
ROA (TTM)	-26166.0%	-12210.0%
ROIC (TTM)	-22168.0%	-33792.0%
Financial Health
Cash	$4M	$516K
Debt	$0	$0
Net Cash/Debt	$4M	$516K
Current Ratio (TTM)	2.09x	3.36x
Quick Ratio (TTM)	2.02x	2.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	-0.79
52W Performance	-26.8%	127.9%
YTD Performance	-18.1%	108.5%
% from 52W High	-42.2%	-21.0%
% from 52W Low	38.7%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.50x
FCF Yield (TTM)	-48.9%	-19.1%
Earnings Yield (TTM)	-37.8%	-15.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCDA research	View INTI research

Valuation

P/S Ratio

INTI

4.25x

BCDA

36.53x

EV/FCF

INTI

-5.09x

BCDA

-1.50x

Growth & revenue

Forward Revenue Growth

BCDA

0.0%

INTI

0.0%

Profitability & performance

Gross Margin

BCDA

100.0%

INTI

20.9%

ROE

BCDA

-22168.0%

INTI

-33792.0%

FCF Yield %

INTI

-19.1%

BCDA

-48.9%

52-Week Performance

INTI

127.9%

BCDA

-26.8%

Detailed metrics comparison

BCDA

BioCardia Inc

INTI

Inhibitor Therapeutics Inc

Market Cap

BCDA$15M

INTI$17M

Enterprise Value

BCDA$11M

INTI$16M

Price

BCDA$1.04

INTI$0.10

P/E Ratio

BCDAN/A

INTIN/A

P/S Ratio

BCDA36.53x

INTI4.25x

EV/Sales

BCDA26.98x

INTI4.12x

EV/EBITDA

BCDA4.97x

INTI1.61x

P/B Ratio

BCDA5.83x

INTI4,922.43x

P/FCF Ratio

BCDAN/A

INTIN/A

EV/FCF

BCDA-1.50x

INTI-5.09x

PEG Ratio

BCDAN/A

INTIN/A

Forward P/E (NTM)

BCDAN/A

INTIN/A

Forward P/S (NTM)

BCDAN/A

INTIN/A

Revenue (TTM)

BCDA$0

INTI$0

Revenue Growth (YoY)

BCDAN/A

INTIN/A

Forward Rev Growth

BCDA0.0%

INTI0.0%

Gross Margin (TTM)

BCDA100.0%

INTI20.9%

Operating Margin (TTM)

BCDA0.0%

INTI0.0%

EBITDA Margin (TTM)

BCDA0.0%

INTI0.0%

Net Margin (TTM)

BCDA0.0%

INTI0.0%

FCF Margin (TTM)

BCDAN/A

INTIN/A

Net Income (TTM)

BCDA$-6M

INTI$-3M

FCF (TTM)

BCDA$-8M

INTI$-3M

EPS (TTM)

BCDA$0.00

INTI$0.00

ROE (TTM)

BCDA-22168.0%

INTI-33792.0%

ROA (TTM)

BCDA-26166.0%

INTI-12210.0%

ROIC (TTM)

BCDA-22168.0%

INTI-33792.0%

Cash

BCDA$4M

INTI$516K

Debt

BCDA$0

INTI$0

Net Cash/Debt

BCDA$4M

INTI$516K

Current Ratio (TTM)

BCDA2.09x

INTI3.36x

Quick Ratio (TTM)

BCDA2.02x

INTI2.95x

Debt/Equity (TTM)

BCDA0.00x

INTI0.00x

Debt/Assets (TTM)

BCDA0.0%

INTI0.0%

Interest Coverage (TTM)

BCDAN/A

INTIN/A

Net Debt/EBITDA (TTM)

BCDA0.00x

INTI0.00x

Beta

BCDA0.63

INTI-0.79

52W Performance

BCDA-26.8%

INTI127.9%

YTD Performance

BCDA-18.1%

INTI108.5%

% from 52W High

BCDA-42.2%

INTI-21.0%

% from 52W Low

BCDA38.7%

INTI180.0%

Asset Turnover (TTM)

BCDA0.14x

INTI0.50x

FCF Yield (TTM)

BCDA-48.9%

INTI-19.1%

Earnings Yield (TTM)

BCDA-37.8%

INTI-15.9%

Dividend Yield (TTM)

BCDAN/A

INTIN/A

Rule of 40

BCDA0.0

INTI0.0

EV/GP/RG

BCDAN/A

INTIN/A

Ticker research

View BCDA research View INTI research

Metric	BCDA BioCardia Inc	INTI Inhibitor Therapeutics Inc
Market & Valuation
Market Cap	$15M	$17M
Enterprise Value	$11M	$16M
Price	$1.04	$0.10
P/E Ratio	N/A	N/A
P/S Ratio	36.53x	4.25x
EV/Sales	26.98x	4.12x
EV/EBITDA	4.97x	1.61x
P/B Ratio	5.83x	4,922.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.50x	-5.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	100.0%	20.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-3M
FCF (TTM)	$-8M	$-3M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-22168.0%	-33792.0%
ROA (TTM)	-26166.0%	-12210.0%
ROIC (TTM)	-22168.0%	-33792.0%
Financial Health
Cash	$4M	$516K
Debt	$0	$0
Net Cash/Debt	$4M	$516K
Current Ratio (TTM)	2.09x	3.36x
Quick Ratio (TTM)	2.02x	2.95x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.63	-0.79
52W Performance	-26.8%	127.9%
YTD Performance	-18.1%	108.5%
% from 52W High	-42.2%	-21.0%
% from 52W Low	38.7%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.14x	0.50x
FCF Yield (TTM)	-48.9%	-19.1%
Earnings Yield (TTM)	-37.8%	-15.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCDA research	View INTI research